Variant #0000831668 (NC_000013.10:g.32912339_32912340del, NM_000059.3:c.3847_3848del (BRCA2))
| Individual ID |
00398067 |
| Chromosome |
13 |
| Allele |
Unknown |
| Affects function (as reported) |
Probably affects function |
| Affects function (by curator) |
Not classified |
| Classification method |
ACMG |
| Clinical classification |
pathogenic (!) |
| DNA change (genomic) (Relative to hg19 / GRCh37) |
g.32912339_32912340del |
| DNA change (hg38) |
g.32338202_32338203del |
| Published as |
- |
| ISCN |
- |
| DB-ID |
BRCA2_001202 See all 88 reported entries |
| Variant remarks |
Not yet with BRCA2 related neoplasm
ACMG: PVS1, PS4_MOD, PM2_SUP 1) This variant has been reported in several individuals and families affected with breast, ovarian, and prostate cancer (PMID: 8589730, 21324516, 23199084, 21952622). 2) It was also shown to segregate with disease in a family with colorectal and other cancers (PMID: 24814045). 3) This variant is also known as 4075delGT in the literature. 4) Loss-of-function variants in BRCA2 are known to be pathogenic (PMID: 20104584). 5) reviewed by the ENIGMA expert panel and classified as pathogenic |
| Reference |
PMID: 8589730, 21324516, 23199084, 21952622, 24814045, 20104584 |
| ClinVar ID |
- |
| dbSNP ID |
- |
| Origin |
Germline |
| Segregation |
- |
| Frequency |
- |
| Re-site |
- |
| VIP |
- |
| Methylation |
- |
| Average frequency (gnomAD v.2.1.1) |
Retrieve |
| Owner |
Andreas Laner |
| Database submission license |
Creative Commons Attribution 4.0 International |
| Created by |
Andreas Laner |
| Date created |
2021-12-31 11:43:11 +01:00 (CET) |
| Date last edited |
2022-01-03 10:18:47 +01:00 (CET) |

Variant on transcripts
Screenings
|